SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-23-000327
Filing Date
2023-01-03
Accepted
2023-01-03 09:18:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM d192937dposam.htm POS AM 19522
  Complete submission text file 0001193125-23-000327.txt   20533
Mailing Address 202 CARNEGIE CENTER SUITE 106 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 106 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-249881 | Film No.: 23500518
SIC: 2836 Biological Products, (No Diagnostic Substances)